97 related articles for article (PubMed ID: 20845375)
1. Influence of Moringa oleifera on pharmacokinetic disposition of rifampicin using HPLC-PDA method: a pre-clinical study.
Pal A; Bawankule DU; Darokar MP; Gupta SC; Arya JS; Shanker K; Gupta MM; Yadav NP; Singh Khanuja SP
Biomed Chromatogr; 2011 Jun; 25(6):641-5. PubMed ID: 20845375
[TBL] [Abstract][Full Text] [Related]
2. Effect of pyrazinamide on rifampicin kinetics in patients with tuberculosis.
Jain A; Mehta VL; Kulshrestha S
Tuber Lung Dis; 1993 Apr; 74(2):87-90. PubMed ID: 8324212
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic interaction of some antitubercular drugs with caraway: implications in the enhancement of drug bioavailability.
Sachin BS; Monica P; Sharma SC; Satti NK; Tikoo MK; Tikoo AK; Suri KA; Gupta BD; Johri RK
Hum Exp Toxicol; 2009 Apr; 28(4):175-84. PubMed ID: 19734267
[TBL] [Abstract][Full Text] [Related]
4. The potential use of urinary excretion data for assessing the relative bioavailability of rifampicin in fixed dose combination anti-tuberculosis formulations.
Pillai G; Ellard GA; Smith PJ; Fourie PB
Int J Tuberc Lung Dis; 2001 Aug; 5(8):691-5. PubMed ID: 11495257
[TBL] [Abstract][Full Text] [Related]
5. Effect of oral administration of crude aqueous extract of garlic on pharmacokinetic parameters of isoniazid and rifampicin in rabbits.
Dhamija P; Malhotra S; Pandhi P
Pharmacology; 2006; 77(2):100-4. PubMed ID: 16699292
[TBL] [Abstract][Full Text] [Related]
6. Potential of Moringa oleifera root and Citrus sinensis fruit rind extracts in the treatment of ulcerative colitis in mice.
Gholap PA; Nirmal SA; Pattan SR; Pal SC; Mandal SC
Pharm Biol; 2012 Oct; 50(10):1297-302. PubMed ID: 22849565
[TBL] [Abstract][Full Text] [Related]
7. Herbal modulation of drug bioavailability: enhancement of rifampicin levels in plasma by herbal products and a flavonoid glycoside derived from Cuminum cyminum.
Sachin BS; Sharma SC; Sethi S; Tasduq SA; Tikoo MK; Tikoo AK; Satti NK; Gupta BD; Suri KA; Johri RK; Qazi GN
Phytother Res; 2007 Feb; 21(2):157-63. PubMed ID: 17128432
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic-pharmacodynamic modeling of rifampicin-mediated Cyp3a11 induction in steroid and xenobiotic X receptor humanized mice.
Raybon JJ; Pray D; Morgan DG; Zoeckler M; Zheng M; Sinz M; Kim S
J Pharmacol Exp Ther; 2011 Apr; 337(1):75-82. PubMed ID: 21205914
[TBL] [Abstract][Full Text] [Related]
9. A rapid and sensitive HPLC-MS method for the detection of plasma and cellular rifampicin.
Hartkoorn RC; Khoo S; Back DJ; Tjia JF; Waitt CJ; Chaponda M; Davies G; Ardrey A; Ashleigh S; Ward SA
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Sep; 857(1):76-82. PubMed ID: 17643357
[TBL] [Abstract][Full Text] [Related]
10. In vivo radioprotective effect of Moringa oleifera leaves.
Rao AV; Devi PU; Kamath R
Indian J Exp Biol; 2001 Sep; 39(9):858-63. PubMed ID: 11831365
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic study of the interaction between rifampin and delavirdine mesylate.
Borin MT; Chambers JH; Carel BJ; Gagnon S; Freimuth WW
Clin Pharmacol Ther; 1997 May; 61(5):544-53. PubMed ID: 9164416
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous determination of rifampicin and sulbactam in mouse plasma by high-performance liquid chromatography.
Aparicio I; Bello MA; Callejón M; Guiraúm A
Biomed Chromatogr; 2006 Aug; 20(8):748-52. PubMed ID: 16252264
[TBL] [Abstract][Full Text] [Related]
13. [Measurement of plasma concentration and bioavailability of nolatrexed dihydrochloride in mice].
Wang GF; Zhang JY; Wu SY; Xu W; Wan SH; Shao CF; Zhang JJ
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Nov; 28(11):1993-5. PubMed ID: 19033111
[TBL] [Abstract][Full Text] [Related]
14. Comparative bioequivalence study of rifampicin and isoniazid combinations in healthy volunteers.
Padgaonkar KA; Revankar SN; Bhatt AD; Vaz JA; Desai ND; D'Sa S; Shah V; Gandewar K
Int J Tuberc Lung Dis; 1999 Jul; 3(7):627-31. PubMed ID: 10423226
[TBL] [Abstract][Full Text] [Related]
15. Comparative bioavailability of rifampicin, isoniazid and pyrazinamide from a four drug fixed dose combination with separate formulations at the same dose levels.
Agrawal S; Singh I; Kaur KJ; Bhade SR; Kaul CL; Panchagnula R
Int J Pharm; 2004 May; 276(1-2):41-9. PubMed ID: 15113612
[TBL] [Abstract][Full Text] [Related]
16. Tamarindus indica L. and Moringa oleifera M. extract administration ameliorates fluoride toxicity in rabbits.
Ranjan R; Swarup D; Patra RC; Chandra V
Indian J Exp Biol; 2009 Nov; 47(11):900-5. PubMed ID: 20099463
[TBL] [Abstract][Full Text] [Related]
17. Formulation of novel sustained release rifampicin-loaded solid lipid microparticles based on structured lipid matrices from Moringa oleifera.
Onyishi IV; Chime SA; Ogudiegwu EO
Pharm Dev Technol; 2015; 20(5):546-54. PubMed ID: 24964095
[TBL] [Abstract][Full Text] [Related]
18. Preclinical pharmacokinetics and bioavailability of noscapine, a tubulin-binding anticancer agent.
Aneja R; Dhiman N; Idnani J; Awasthi A; Arora SK; Chandra R; Joshi HC
Cancer Chemother Pharmacol; 2007 Nov; 60(6):831-9. PubMed ID: 17285314
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic interaction between rifampicin and the once-daily combination of saquinavir and low-dose ritonavir in HIV-infected patients with tuberculosis.
Ribera E; Azuaje C; Lopez RM; Domingo P; Curran A; Feijoo M; Pou L; Sánchez P; Sambeat MA; Colomer J; Lopez-Colomes JL; Crespo M; Falcó V; Ocaña I; Pahissa A
J Antimicrob Chemother; 2007 Apr; 59(4):690-7. PubMed ID: 17307771
[TBL] [Abstract][Full Text] [Related]
20. Concomitant administration of Moringa oleifera seed powder in the remediation of arsenic-induced oxidative stress in mouse.
Gupta R; Dubey DK; Kannan GM; Flora SJ
Cell Biol Int; 2007 Jan; 31(1):44-56. PubMed ID: 17055307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
